These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36756104)

  • 1. Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience.
    Demir M; Güven D; Aktaş BY; Güner G; Aktepe OH; Taban H; Karakaş Y; Kılıçkap S; Kars A; Türker A; Dizdar Ö
    South Asian J Cancer; 2022 Oct; 11(4):287-292. PubMed ID: 36756104
    [No Abstract]   [Full Text] [Related]  

  • 2. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.
    Fabre-Guillevin E; Coindre JM; Somerhausen Nde S; Bonichon F; Stoeckle E; Bui NB
    Cancer; 2006 Jun; 106(12):2725-33. PubMed ID: 16688768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of multiply recurrent retroperitoneal liposarcoma: A single-center experience.
    Masaki N; Onozawa M; Inoue T; Kurobe M; Kawai K; Miyazaki J
    Asian J Surg; 2021 Jan; 44(1):380-385. PubMed ID: 33191070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paratesticular liposarcoma: a clinicopathologic study.
    Montgomery E; Fisher C
    Am J Surg Pathol; 2003 Jan; 27(1):40-7. PubMed ID: 12502926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and Outcomes of Locally Recurrent Retroperitoneal Sarcoma After First Relapse in a Single Tertiary Asian Centre and Applicability of the
    Lim HJ; Wong R; Koh YS; Ho ZS; Ong CJ; Farid M; Teo CCM
    Front Oncol; 2021; 11():730292. PubMed ID: 34900680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
    Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
    Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retroperitoneal dedifferentiated liposarcomas: semi-quantitative assessment of the dedifferentiated component and prognosis].
    Volkov AY; Kozlov NA; Nered SN; Stilidi IS; Stroganova AM; Arkhiri PP; Antonova EY; Privezentsev SA
    Arkh Patol; 2020; 82(5):25-32. PubMed ID: 33054029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary intrathoracic liposarcomas: A clinicopathologic and molecular study of 43 cases in one of the largest medical centers of China.
    Xie Y; Jing W; Zhao W; Peng R; Chen M; Lan T; Peng H; He X; Chen H; Zhang Z; Zhang H
    Front Oncol; 2022; 12():949962. PubMed ID: 36059611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDIT3 Expression in Liposarcoma Development.
    Kåbjörn Gustafsson C; Engström K; Aman P
    Sarcoma; 2014; 2014():954671. PubMed ID: 24790523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of histologic subtypes in primary extremity liposarcoma.
    Chang HR; Hajdu SI; Collin C; Brennan MF
    Cancer; 1989 Oct; 64(7):1514-20. PubMed ID: 2776110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
    Thway K; Flora R; Shah C; Olmos D; Fisher C
    Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Established and Experimental Systemic Treatment Options for Advanced Liposarcoma.
    Schöffski P
    Oncol Res Treat; 2022; 45(9):525-543. PubMed ID: 35609512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigen I is significantly downregulated in patients with myxoid liposarcomas.
    Oike N; Kawashima H; Ogose A; Hatano H; Ariizumi T; Yamagishi T; Murayama Y; Umezu H; Imai C; Hayashi M; Endo N
    Cancer Immunol Immunother; 2021 Dec; 70(12):3489-3499. PubMed ID: 33893830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features.
    Boland JM; Colby TV; Folpe AL
    Am J Surg Pathol; 2012 Sep; 36(9):1395-403. PubMed ID: 22895273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposarcomas of the mediastinum.
    Suster DI; Suster S
    Mediastinum; 2020; 4():27. PubMed ID: 35118295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposarcoma of the oral and salivary gland region: a clinicopathologic study of 18 cases with emphasis on specific sites, morphologic subtypes, and clinical outcome.
    Fanburg-Smith JC; Furlong MA; Childers EL
    Mod Pathol; 2002 Oct; 15(10):1020-31. PubMed ID: 12379747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy.
    Kim HS; Lee J; Yi SY; Jun HJ; Choi YL; Ahn GH; Seo SW; Lim DH; Ahn YC; Park JO; Kim SJ
    BMC Cancer; 2009 Jun; 9():205. PubMed ID: 19558664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary mediastinal liposarcoma: clinicopathologic analysis of 24 cases.
    Hahn HP; Fletcher CD
    Am J Surg Pathol; 2007 Dec; 31(12):1868-74. PubMed ID: 18043041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of age and subtype in outcome of operable liposarcoma.
    Greto D; Saieva C; Loi M; Terziani F; Visani L; Garlatti P; Lo Russo M; Muntoni C; Becherini C; Topulli J; Campanacci D; Beltrami G; Scoccianti G; Muratori F; Bonomo P; Desideri I; Francolini G; Livi L
    Radiol Med; 2019 Apr; 124(4):290-300. PubMed ID: 30421387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of patients with extremity myxoid liposarcomas after surgery.
    Wu J; Qian S; Jin L
    J Orthop Surg Res; 2019 Mar; 14(1):90. PubMed ID: 30922351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.